It has been shown that SIRT1 and NF-κB activation have antagonistic activity in the regulation of metabolism (e.g., gluconeogenesis, glycolysis, fatty acid oxidation, and synthesis, oxidative phosphorylation, mitochondrial biogenesis, etc.)including insulin resistance and inflammation [130,131,132]. The gene discussed is SIRT1; the disease is Insulin resistance.